Key facts
- This page summarizes J. Kevin Buchi's Form 4 filing for Amneal Pharmaceuticals, Inc. (AMRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Sep 2026, 16:10.
J. Kevin Buchi - 11 Sep 2026 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)
- Reporting relationship
- Director
- Issuer ticker
- AMRX
- Reported as of
- 11 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Sep 2026, 16:10:38 UTC
- Prior SEC filing
- 13 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Denis Butkovic, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
J. Kevin Buchi filed Form 4 for Amneal Pharmaceuticals, Inc. (AMRX) on 14 Sep 2026.
Change
- Previous filing in this sequence was filed on 13 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001209726
Primary reporting owner
BUCHI J KEVIN
- Relationship
- Director
- Address
- C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER
- Signature
- /s/ Denis Butkovic, Attorney-in-Fact
- Signature date
- 14 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMRX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +20,445
- Change %
- +27%
- Price
- $14.45*
- Shares after
- 95,522
- Date
- 11 Sep 2026
- Ownership
- Direct
AMRX
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 93,499
- Date
- 11 Sep 2026
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMRX
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- Shares
- -20,445
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Sep 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 20,445
- Exercise price
- $14.45
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option is vested and currently exercisable.